Millipede AspiRation for Revascularization in Stroke (MARRS) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Ribo, MD
Vall D'Hebron Hospital, Barcelona, Spain
Principal Investigator - Raul Nogueira, MD
University of Pittsburgh Medical Center (UPMC), Pittsburgh, USA
Principal Investigator - Ricardo Hanel, MD
Baptist Health Research Institute, Jacksonville, USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Bordeaux
Bordeaux, France
- Chu Montpellier
Montpellier, France
- Chru de Nancy
Nancy, France
- Chu de Nantes - Hgrl
Nantes, France
- Chru Strasbourg
Strasbourg, France
- Toulouse University Hospital -Chu Purpan
Toulouse, France
- Vall D'Hebron
Barcelona, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Yale University Hospital
New Haven, Connecticut, United States
- Baptist Health Research Institute
Jacksonville, Florida, United States
- Tampa General Hosital
Tampa, Florida, United States
- Emory
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- University of Rochester Medical Center (urmc)
Rochester, New York, United States
- Stony Brook University Hospital
Stony Brook, New York, United States
- Mercy Health
Toledo, Ohio, United States
- Promedica Toledo Hospital
Toledo, Ohio, United States
- University of Toledo
Toledo, Ohio, United States
- Oregon Health & Science University (ohsu)
Portland, Oregon, United States
- University of Pittsburgh Medical Center (upmc)
Pittsburgh, Pennsylvania, United States
- Semmes Murphey Foundation
Memphis, Tennessee, United States
- Valley Baptist Medical Center
Harlingen, Texas, United States
- Ut Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2023
- Primary completion
- 8 Mar 2025
- Completion
- 12 May 2025
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 235
- Registry id
- NCT05714501
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.